Scarica l'app Stockscreener
53.89
0.97%
0.52
Dopo l'orario di chiusura:
53.98
0.09
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$53.37
Aprire:
$53.37
Volume 24 ore:
479.68K
Relative Volume:
1.45
Capitalizzazione di mercato:
$1.86B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-14.68
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
-2.62%
1M Prestazione:
-0.33%
6M Prestazione:
+11.11%
1 anno Prestazione:
-16.35%
Intervallo 1D:
$52.35
$54.95
Intervallo di 1 settimana:
$52.35
$57.19
Portata 52W:
$25.60
$68.86
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
53.89 | 1.86B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine’s (IRON) Overweight Rating Reiterated at Morgan Stanley - Defense World
Certain Common Stock of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2025. - Marketscreener.com
FY2025 EPS Forecast for Disc Medicine Increased by Analyst - Defense World
Disc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at Scotiabank - MarketBeat
New York State Common Retirement Fund Cuts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Rhumbline Advisers Purchases 1,553 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Price Target Raised to $75.00 at Scotiabank - Defense World
Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know - Yahoo Finance
Disc Medicine price target raised to $75 from $73 at Scotiabank - TipRanks
Leerink Partnrs Comments on Disc Medicine Q1 Earnings - Defense World
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus.com
Disc Medicine (NASDAQ:IRON) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Promising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health - TipRanks
(IRON) Proactive Strategies - Stock Traders Daily
Disc Medicine’s 2024 Financial Results and Clinical Progress - TipRanks
Disc Medicine's Annual Loss Widens in 2024 -February 27, 2025 at 09:33 am EST - Marketscreener.com
TD Cowen Initiates Coverage on Disc Medicine With Buy Rating -February 27, 2025 at 08:31 am EST - Marketscreener.com
Disc Medicine, Inc. SEC 10-K Report - TradingView
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Disc Medicine, Inc. Reports Financial Results and Key Clinical Developments, Targeting NDA Submission for Bitopertin in EPP by H2 2025 - Nasdaq
TD Cowen starts Disc Medicine stock with Buy rating By Investing.com - Investing.com UK
Disc Medicine initiated with a Buy at TD Cowen - TipRanks
How Disc Medicine's $490M War Chest Is Fueling Its Path to First FDA Approval - StockTitan
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Insider Pamela Stephenson Sells 3,137 Shares - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Disc medicine officer sells shares worth $171,217 By Investing.com - Investing.com UK
Disc Medicine’s chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Nigeria
Disc Medicine's chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Australia
Disc medicine COO Yu sells $87,873 in stock By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $304,228 in stock By Investing.com - Investing.com Nigeria
Disc medicine officer sells shares worth $171,217 - Investing.com India
Disc medicine COO Yu sells $87,873 in stock - Investing.com
Disc Medicine's chief medical officer sells shares worth $89,402 - Investing.com
Disc Medicine CEO John Quisel sells $304,228 in stock - Investing.com
Disc Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Disc Medicine CEO Sells Shares to Cover Tax Obligations - TradingView
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.4% - Defense World
Disc Medicine's SWOT analysis: rare blood disorder stock poised for growth - Investing.com Nigeria
How To Trade (IRON) - Stock Traders Daily
Disc Medicine announces pricing of $225.5M upsized public offering - MSN
Bleakley Financial Group LLC Invests $486,000 in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
FY2025 EPS Estimates for Disc Medicine Increased by Analyst - MarketBeat
Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
Disc Medicine FY2025 EPS Forecast Lifted by Leerink Partnrs - Defense World
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
2.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):